DHA Support for SB 194 HIV PrEP/PEP

Frame-Shape

On January 17, 2024, DHA sent a letter to Senator Sarah McBride in support of SB 194 to allow pharmacists to provide HIV pre-exposure and post-exposure prophylaxis treatments (PrEP and PEP, respectively).

​Click here to read the letter.

Related Links

divider-shape

Comments – Request for Information: 340B Rebate Model Pilot Program, HHS Docket No. HRSA-2026-03042

Comments on Hospital Discharge Plans for Pregnant Patients (SB 301)

No results found.